Cargando…
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast
Malignant phyllodes tumor is a rare breast malignancy with sarcomatous overgrowth and with limited effective treatment options for recurrent and metastatic cases. Recent clinical trials indicated a potential for anti-angiogenic, anti-EGFR and immunotherapeutic approaches for patients with sarcomas,...
Autores principales: | Gatalica, Zoran, Vranic, Semir, Ghazalpour, Anatole, Xiu, Joanne, Ocal, Idris Tolgay, McGill, John, Bender, Ryan P., Discianno, Erin, Schlum, Aaron, Sanati, Souzan, Palazzo, Juan, Reddy, Sandeep, Pockaj, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811491/ https://www.ncbi.nlm.nih.gov/pubmed/26625196 |
Ejemplares similares
-
Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas
por: Topcagic, Jasmina, et al.
Publicado: (2018) -
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine
por: Gatalica, Zoran, et al.
Publicado: (2016) -
Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast
por: Vranic, Semir, et al.
Publicado: (2018) -
Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast
por: Vranic, Semir, et al.
Publicado: (2020) -
Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers
por: Vranic, Semir, et al.
Publicado: (2022)